Under construction – not a live service
Sign in

NCT07442110Completed

This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

Observational Study of a Specialized Dietary Supplements on the Healing of Diabetic Foot Ulcers and Prevention of Amputations

Source: ClinicalTrials.gov · Last updated 4 Mar 2026

Next steps

Brief summary (registry, in English)

This observational study evaluates the clinical outcomes of patients with diabetes who utilize a specialized dietary supplements for foot ulcer healing. The study documents the rate of complete wound closure and the prevention of lower extremity amputations in a real-world, at-home setting.

Status (registry)
Completed
Study type
Observational
Enrollment
35 (actual)
First submitted
12 Feb 2026
Start date
5 Jul 2025
Primary completion date
2 Sept 2025
Lead sponsor
Amar h Zireg
NCT number
NCT07442110

What you commit to

  • Study type: Observational
  • Participants enrolled: 35
  • From 5 Jul 2025 to the primary completion date, 2 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnancy or breastfeeding.
  • Pregnant women

Who the study is looking for

  • Diagnosis of Type 1 or Type 2 Diabetes Mellitus. Presence of at least one chronic diabetic foot ulcer (DFU) classified as Wagner Grade 1 to 5.
  • Patients currently facing potential lower extremity amputation as recommended by a surgical consultation.
  • Patients currently adhering to the specific dietary supplements protocol for wound healing.
  • Ability to participate in a 6-week clinical observation period with weekly monitoring.
  • Age 18 years and older.

Age in the registry: 25 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Amar hocine ZiregBordj Bou ArreridjAlgeriaUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.